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Abstract
Background: Schizophrenia aggregates in families and accurate diagnoses are essential for genetic
studies of schizophrenia. In this study, we investigated whether siblings of patients with
schizophrenia can be identified as free of any psychotic disorder using only register information.
We also analyzed the emergence of psychotic disorders among siblings of patients with
schizophrenia during seven to eleven years of follow-up.  
Methods:  A genetically homogenous population isolate in north-eastern Finland having 365
families with 446 patients with a diagnosis of schizophrenia was initially identified in 1991 using four
nationwide registers. Between 1998 and 2002, 124 patients and 183 siblings in 110 families were
contacted and interviewed using SCID-I, SCID-II and SANS. We also compared the frequency of
mental disorders between siblings and a random population comparison group sample.
Results: Thirty (16%) siblings received a diagnosis of psychotic disorder in the interview. 14
siblings had had psychotic symptoms already before 1991, while 16 developed psychotic symptoms
during the follow-up. Over half of the siblings (n = 99, 54%) had a lifetime diagnosis of any mental
disorder in the interview.
Conclusion: Register information cannot be used to exclude psychotic disorders among siblings
of patients with schizophrenia. The high rate of emergence of new psychotic disorders among
initially healthy siblings should be taken into account in genetic analysis.
Background
Family studies of schizophrenia have established that
schizophrenia strongly aggregates in families with a rela-
tive risk of about 11 compared with matched comparison
groups. When we investigate affected pedigrees, there is a
relatively high risk that healthy pedigree members
develop schizophrenia or other psychotic disorder in the
future, although recent genetic studies of schizophrenia
have not investigated this. Further, the current evidence
suggests that familial liability to schizophrenia increases
not only the risk for schizophrenia as narrowly defined,
but also for personality disorders of the schizophrenia
spectrum and probably several psychotic illnesses [[1-3],
see reviews [4,5]].
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Identification of "healthy" siblings, patients with schizophrenia or schizoaffective disorder, and comparison group Figure 1
Identification of "healthy" siblings, patients with schizophrenia or schizoaffective disorder, and comparison group.
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Genetic studies of schizophrenia are expensive, mainly
because of the need to conduct structured clinical inter-
views of all family members. If psychotic disorders could
be reliably excluded using data from nationwide health
care registers, the costs would be greatly reduced as struc-
tured interviews would not be needed for all healthy fam-
ily members.
The aims of this study were to investigate whether siblings
of patients with schizophrenia can be identified as not
having any psychotic disorder using health care register
information only, to analyze the emergence of psychotic
disorders among siblings of patients with schizophrenia
during seven to 11 years of follow-up, and to compare the
prevalence of psychiatric disorders between siblings of
patients with schizophrenia and a random population
sample.
Methods
This study was based on a genetically homogenous popu-
lation isolate in north-eastern Finland where the preva-
lence and lifetime morbid risk of schizophrenia are
substantially higher than elsewhere in the country [6,7],
and where chromosomal regions suggesting putative loci
for genes predisposing to schizophrenia in families have
also been found [8-13].
The study was initially started in 1991, and from the
beginning we have collaborated with the Department of
Molecular Medicine, National Public Health Institute,
Helsinki, Finland. All phases of the study were approved
by the review board of Finland's National Public Health
Institute, and the Ministry of Social Affairs and Health. All
patients and siblings gave informed consent and patients
gave permission to contact their family members.
Registers
In 1991 we used three registers to identify schizophrenia
patients born between 1940 and 1969 who had at least
one parent born in the internal isolate. The Finnish Hos-
pital Discharge Register records diagnoses and admission
and discharge dates for all inpatient stays in both public
and private hospitals. The Pension Register records disa-
bility pensions and the Free Medicine Register records
state subsidized outpatient medication. The registers were
computerized in 1969. The registers used the ICD-8 [14]
criteria before 1987, the Finnish version of the ICD-9 [15]
applying DSM-III-R diagnostic criteria for mental disor-
ders [16] from 1987 to 1995, and the ICD-10 [17] diag-
nostic codes from 1996. In our own diagnostic
reassessment, 69% of the subjects with a register diagnosis
of schizophrenia, schizoaffective, or schizophreniform
disorder received a diagnosis of schizophrenia, and 87%
received any schizophrenia spectrum diagnosis [6]. This
accords with another validation study from the isolate
sample [18], while in the North Finland 1966 Birth
Cohort there have been no false positive schizophrenia
diagnosis in the Hospital Discharge Register [19,20].
Identification of patients and "healthy" siblings
We identified 365 families with 466 patients with register-
based diagnosis of schizophrenia, schizoaffective or schiz-
ophreniform disorder and 1353 siblings from the
National Population Register (born 1940–1969) with no
register-based diagnosis of psychotic disorder (Fig. 1.).
Between 1991 and 2002, we contacted these families to
collect blood samples for genetic analyses. Of the 446
patients, 69 had deceased, and 82 refused from the blood
sample. Personal interviews were not conducted, but
DSM-IV [21] diagnoses for affected family members were
made using the information in psychiatric case notes from
all hospital and outpatient treatment facilities [8,22].
We re-contacted these families between 1998 and 2002
and asked them to participate in face-to-face assessments
including an extensive neuropsychological examination
and a structured interview. The aim of the follow-up was
to ascertain psychiatric diagnoses and to collect more
detailed phenotypic data. We also obtained information
from the Finnish Hospital Discharge Register on hospital
treatments for mental disorders between 1991 and 1998
for both patients and siblings.
We contacted all patients who had previously participated
in genetic studies and had a consensus diagnosis. How-
ever, 23 patients refused to take part to the interview and
tests. We also interviewed siblings of the contacted
patients. We could not contact all "healthy" siblings, but
for every patient we aimed to interview and test at least
one sibling nearest by age [23]. This age criterion was set
because we wanted to minimize age-related differences in
neuropsychological performance between siblings.
For this study, we included all patients with a SCID inter-
view diagnosis of schizophrenia or schizoaffective disor-
der (n = 183, Fig. 1.). 124 patients (97 schizophrenia, 27
schizoaffective disorder) had at least one sibling born
from 1940 to 1969 who had no register diagnosis of psy-
chotic disorder in 1991 and who was interviewed. 59
patients had no sibling fulfilling the inclusion criteria. The
final sample of 110 families with at least one patients-sib-
ling pair consisted of 124 patients and 183 siblings.
Fifty-nine (54%) of 110 families had one interviewed
patient and sibling, 24 families had two siblings, 12 three,
one four and one six siblings per one patients. In twelve
families we had two patients: five families had one sib-
ling, two had two, three had three, and two families had
four interviewed siblings. Finally, in one family there were
three patients and four interviewed siblings.BMC Psychiatry 2006, 6:6 http://www.biomedcentral.com/1471-244X/6/6
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Comparison group for siblings
Comparison group (n = 111) were a representative sample
of the Finnish general population aged 30–79 (Fig. 1).
The sample was collected from the Health 2000 Survey,
which is based on a nationally representative two-stage
cluster sample of 8028 persons aged 30 or over [24]. Of
the 161 subjects randomly selected from those who had
participated in any of the study phases, 111 (68.9 %) were
interviewed during 2002–2004 and were taken as com-
parison group for this study. Information on hospital
treatments for any psychotic disorders for them was
obtained from the Hospital Discharge Register from 1974
to 2002.
The interviews and assessments
We interviewed 183 siblings, 124 patients and 111 indi-
viduals from the comparison group with SCID-I (Struc-
tured Clinical Interview for DSM-IV axis disorders [25]
(Fig 1). We interviewed the siblings and the patients with
SCID-II [25] and all patients and 113 siblings with the
Scale for the Assessment of Negative Symptoms (SANS)
[26].
We used the clinician version of SCID-I (DSM-IV), which
contains an overview and six modules: mood episodes,
psychotic symptoms, psychotic disorders, mood disor-
ders, substance use disorders and anxiety and other disor-
ders. The SCID-I and -II scoresheets were translated into
Finnish and we added some questions to the overview
scoresheet.
The SANS [26] consists of 25 items and is rated on 0 – 5
scale. It has 5 subscales: affective flattening or blunting,
alogia, apathy, asociality, and inattention.
The four teams of field workers had received extensive
training in use of the instruments. The reliability for SCID-
III-R and SCID-IV has been high [27,28]. To increase reli-
ability we tape-recorded and reviewed the 20 first inter-
views of each fieldworker. The SCID-I-II and SANS
interviews were also reviewed by the senior researcher.
The interviews were made on a lifetime basis and blind to
the register diagnosis. Comparison group was interviewed
using SCID-I only.
Statistical methods
We calculated the percentages of each mental disorder in
the study groups according to the SCID interview data
with SPSS 11.0 for Windows. We also counted the fre-
quencies of co-morbid mental disorders, as well as socio-
demographic and clinical characteristics like sex, age,
education years, current and lifetime psychiatric treat-
ment, and medication.
We took the within-family correlation into account by
using conditional logistic regression and general estima-
tion equations (GEE, version 4.13) [29] in our analysis.
We had family as the stratification variable, psychosis as
the dependent variable and age (40–49, 50–59, 60–69
years), sex, residence (city, population centres, rural), con-
tact for mental health problems, contact for alcohol or
substance use problems and smoking as explanatory vari-
ables. We also tested the results of 113 SANS interviews of
"healthy" siblings using the same logistic regression anal-
ysis, with the diagnosis of psychosis as the dependent var-
iable and the SANS items without global ratings as
explanatory variables.
We also checked the register diagnoses of 183 interviewed
siblings seven years later (31 Dec 1998) to find out if the
"healthy" siblings had received any register diagnosis of
psychotic disorder in the meantime.
Results
Psychotic disorders among siblings of patients with 
schizophrenia
In the SCID interview there were 30 (16.4 %) siblings with
a diagnosis of psychotic disorder among the 183 siblings
with no register diagnosis of psychotic disorder in regis-
ters in 1991. Diagnosis were one schizophrenia, six
schizoaffective psychoses, three delusional disorders,
eight psychotic disorders not otherwise specified, and six
were psychotic mood disorders (two bipolar and four psy-
chotic major depressive disorders), and six were sub-
stance-induced psychotic disorders (four alcohol-induced
and two other substance-induced psychotic disorders).
Fourteen siblings had had psychotic symptoms before
1991(see Table 1.).
The mean age of onset of psychotic symptoms among 30
siblings according to SCID interview was 33.5, SD 8.7
years. Those 14 siblings who had psychotic symptoms
before 1991 had the mean age of onset 26.1, SD 9.4 versus
38.4, SD 5.2 years among those 16 siblings with onset of
psychotic symptoms in the follow-up. The age at onset
distribution ranged from 52 years to one sibling who had
had psychotic symptoms already in childhood but could
not remember the age of onset.
Siblings who had contacted health care professionals for
mental health problems (OR = 7.0, CI 2.6–18.9), for alco-
hol or substance use problems (OR = 8.8, CI 1.6–49.2) or
smoked (OR = 2.4, CI 0.85–6.9) had the highest odds
ratios explaining the diagnosis of psychotic disorder. Sex,
age, or education years did not predict psychosis among
the 183 siblings.
Of all 30 siblings with an interview-based diagnosis of
psychotic disorder, seven (23%) had had a hospital treat-BMC Psychiatry 2006, 6:6 http://www.biomedcentral.com/1471-244X/6/6
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ment because of psychotic disorder between 1991 and
1998 according to the Hospital Discharge Register. How-
ever, only one of them belonged to the group that had
developed psychotic symptoms before 1991. Less than
half (43%) had current psychiatric treatment or medica-
tion (Table 2).
We also analysed the SANS ratings of 113 siblings with
logistic regression analysis. The items 3 (paucity of expres-
sive gestures), 7 (lack of vocal inflections), 15 (impersist-
ence at work or school) and 18 (recreational interests and
activities) had statically significant odds ratios of 4.6 (CI
0.9–21.8), 2.4 (CI 0.7–8.8), 3.0 (CI 1.8–4.9) and 2.1 (CI
0.9–4.9) respectively, and were associated with the diag-
nosis of psychotic disorder.
Non-psychotic disorders among siblings of patients with 
schizophrenia
There were 69 non-psychotic disorders among siblings of
patients with schizophrenia (28 non psychotic depressive,
seven personality A, four other personality, seven alcohol
use, 22 anxiety disorders, and one sleep disorder, Table 1).
In addition, 43 of 183 siblings had co-morbid diagnoses
in the SCID interview.
During the follow up, from 1991 to 1998, 11 (7.2%) of
interviewed 153 non-psychotic siblings had been hospi-
talised (Table 2).
Siblings of patients with schizophrenia compared to 
comparison group
Demographic and clinical characteristics of siblings (n =
183) and comparison group (n = 111) are presented in
Table 2. Individuals in the comparison group were older
and had higher current GAF ratings (mean 79.2, SD 12.5
versus mean 73.7, SD 14.9, p = 0.002) than the siblings.
Siblings had significantly more diagnoses of psychotic dis-
orders (16% versus 2%, p < 0.0001) than comparison
groups in the SCID-I interview (Table 1). In addition sib-
lings did not have more organic diseases or medication
than comparison groups.
When we made the analysis using only one interviewed
sibling nearest in age to the patients, the result was the
same: 14.5% psychoses and 52% mental disorders among
siblings.
Discussion
Our results clearly show that nationwide health care regis-
ters cannot be used to exclude psychotic disorders in rela-
Table 1: SCID-I-II principal diagnosis of 183 healthy siblings, and SCID-I diagnosis of 111 individuals from the comparison group. In 
brackets number of those 14 siblings who had psychotic symptoms before 1991.
Isolate siblings Comparison group
N 183 111
Psychotic disorders
Schizophrenia 1 (1) 0.5% 1 0.9%
Schizoaffective disorder 6 (2) 3.3%
Delusional disorder 3 (1) 1.6%
Psychotic disorder NOS 8 (4) 4.4%
Alcohol-induced psychotic disorders 4 (3) 2.2% 1 0.9%
Other substance-induced psychotic disorders 2 (1) 1.1%
Major depressive disorder with psychotic 
features
4 (1) 2.2%
Bipolar disorder I 2 (1) 1.1%
Other mental disorders
Other depressive disorders 28 15.3% 21 18.9%
Personality disorders A * 7 3.8% not assessed
Personality disorders B-C* 4 2.2% not assessed
Alcohol use disorders 7 3.8% 14 12.6%
Anxiety disorders 22 12.0% 8 7.2%
Other 1 0.5%
Diagnosis 99 54.1% 45 40.5%
No diagnosis 84 45.9% 66 59.5%
Total 183 99.9% 111 100%
*5 siblings had SCID-II personality disorder without other diagnosis.
Siblings had 43 (23.5%) co-morbid diagnoses: 15 (8.2%) alcohol use, 15 anxiety (8.2%), and 6 (3.3%) other depressive disorders, 5 (2.7%) personality 
disorders (2 cluster A and 3 cluster B-C), one anxiolytic dependence disorder and one hypochondriasis. Comparison group had 10 (9.0%) co-
morbid diagnoses: 5 anxiety and 5 alcohol use disorders.BMC Psychiatry 2006, 6:6 http://www.biomedcentral.com/1471-244X/6/6
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tives of patients with schizophrenia. In 1991, when the
study was initially launched, 7.7% of the siblings who
were presumed to be healthy based on Hospital Discharge
Register actually had psychotic symptoms. The number of
false negatives would be high enough to jeopardize the
results of genetic analyses, if these siblings were treated as
unaffected in the analyses. Even if the "healthy" siblings
were treated as unknown, as is the current practice, the
analyses would have compromised power compared to
more exact diagnoses.
The rate of emergence of new psychotic disorders among
siblings during the relatively short follow-up time was
also high. Between 1991 and 1998, 8.7% of the siblings
developed any psychotic disorder, although their mean
age in 1991 was already 37 years. The high rate of new-
onset psychotic disorders reflects the fact that many sib-
lings came from multiply affected families.
In 1991, many families already had several members with
schizophrenia or schizoaffective disorder. The majority of
"healthy" siblings had at that time already passed the
greatest risk period for schizophrenia, which explains why
only one "healthy" sibling received a diagnosis of schizo-
phrenia during the follow-up. However, there were six
with schizoaffective disorder and another six with psy-
chotic affective disorders. In two families the schizoaffec-
tive and affective psychotic disorders were clustered with
three and four affected siblings in the family. We also
found three families with two new cases of psychotic dis-
orders. Our findings accord with several family studies
which have reported a high risk not only for schizophre-
nia and schizoaffective disorders but also for affective dis-
orders within families [1-3,30]. Similar findings were seen
in a study of extended pedigrees where all patients had a
diagnosis of schizophrenia [31].
Although only one sibling received a diagnosis of schizo-
phrenia, particularly the eight siblings with psychosis not
otherwise specified might have been presenting premor-
bid symptoms of schizophrenia, the possibility of which
can only be ruled out by a longer follow-up study.
In seven years of follow-up only seven siblings were hos-
pitalized with a diagnosis of psychotic disorder, although
all 30 siblings with an interview diagnosis of psychotic
disorder had had psychotic symptoms before 1998. So,
using the SCID interview allowed us to identify better and
earlier the siblings with psychotic disorders. On the other
hand the amount of psychiatric inpatient beds decreased
dramatically in Finland in 1990s, and this might have lead
to the more stringent indications of hospitalization. How-
ever, siblings with psychotic disorders had had more con-
tacts to health care professionals for mental health
problems and alcohol or substance use problems. This
suggest that when persons who have several relatives with
schizophrenia or other psychotic disorders seek help for
any mental, alcohol or substance use problems psychotic
symptoms should always be assessed carefully.
16% of the siblings had a diagnosis of psychotic disorder
compared with 2% of the comparison group. Axis-I psy-
chiatric morbidity was common both in siblings (51%)
and in comparison groups (41%). The frequency of anxi-
ety disorders was higher among siblings than comparison
group, contrary to some other studies [5,31]. In addition,
siblings more often had co-morbid diagnoses (24%) than
the comparison group (6%), suggesting that their clinical
Table 2: Demographic and clinical characteristics of subjects
Patients Psychotic siblings Non psychotic siblings Comparison group
N 124 30 153 111
Age at evaluation, y, mean (SD), 
(min, max)
46.0 (7.3) (31.2 – 64.9) 44.4 (6.3) (32.0 – 61.0) 46.4 (8.8) (24.0 – 72.0) 50.3 (12.3) (30.3–78.0)
Sex of subjects, % male 81 65.3 % 16 53.3% 73 47.7% 56 50.5%
Education, y, mean (SD) 9.5 (2.3) 10.5 (2.1) 11.4 (3.0) 11.7 (4.0)
Ever had psychiatric treatment/
medication
123 99.2 % 22 73.3 % 46 30.1 % 31 27.9%
Ever treated in psychiatric 
hospital
121 97.5% 9 30.0% 11 7.2% 4 3.6 %
Current psychiatric treatment/
medication
117 94.4 % 13 43.3 % 19 12.4 % 16 14.4%
Current use of psychiatric 
medicine
117 94.4 % 13 43.3 % 19 12.4 % 12 10.8%
Antipsychotics 116 93.5 % 8 26.8 % 4 2.6 % 3 2.7%
Antidepressants 25 20.2 % 9 30.0 % 6 3.9 % 4 6.6%
Anxiolytics or sedatives 54 43.5 % 10 33.3 % 8 5.2 % 5 4.5%
GAF current (SD) 36.3 (11.3) 54.9 (11.8) 77.5 (12.5) 79.2 (12.9)BMC Psychiatry 2006, 6:6 http://www.biomedcentral.com/1471-244X/6/6
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status was more complicated and they were possible more
seriously affected.
"Paucity of expressive gestures" and "lack of vocal inflec-
tions" as negative symptoms are phenotypic features that
could benefit genetic analysis in addition to clinical diag-
nosis. We found in our previous studies that patients with
first-degree relatives with psychotic disorder had more
severe negative symptoms than patients without familial
loading for schizophrenia [32].
Limitations
Research environment in Finland is unique because of the
extensive health care registers, which allow us to identify
and follow up patients. However, findings based to regis-
ter data are not generalizable to countries without such
registers.
Comparison group is a representative sample of the Finn-
ish general population but it might not be representative
of the population originating from the isolate. We meas-
ured only DSM-IV axis I, but did not use SCID-II.
We did not calculate the reliability of the interview
method, but in our earlier study the SCID interview iden-
tified more affective disorders than the best estimate con-
sensus diagnoses [6]. However, our interviewers were
well-trained and they reviewed the interviews with senior
researchers. Patients were interviewed before the siblings,
and siblings and interviewers were not aware of patients'
diagnoses. Nevertheless, it was difficult for the interview-
ers to remain completely blind to the status of family
members, because the participants often wanted to dis-
cuss about the situation in their family.
Negative symptoms were measured with SANS, but only
113 of 183 siblings and no comparison groups were inter-
viewed. Moreover, SANS has not been validated or even
used in general population. The reliability of SANS has
been evaluated by Andreasen and colleagues as excellent
[33,34]. However, Norman and colleagues [35] found
that the interrater reliability on the whole was lower than
reported earlier. So our result that paucity of expressive
gestures associate with psychosis in siblings is prelimi-
nary.
Conclusion
Register information cannot be used to exclude psychotic
disorders among siblings of patients with schizophrenia.
Furthermore, during a relatively short follow-up, 8.7% of
initially healthy siblings developed some psychotic disor-
der. The high rate of emergence of new psychotic disor-
ders among initially healthy siblings should be taken into
account in genetic analysis, and it also encourages the use
of endophenotypes instead of reliance on psychiatric
diagnoses alone.
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